Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Clinical and Molecular Hepatology. 2019;25(1):74-85 
Superselective Transarterial Chemoembolization for Hepatocellular Carcinoma: Recent Progression and Perspective
Oncology. 2011;81(s1):105-110
Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?
Korean Journal of Radiology. 2015;16(5):1068
4:21 PM Abstract No. 281 Long-term outcomes in superselective transarterial chemoembolization using lipiodol with 3D: safety margin versus radiofrequency ablation for solitary small hepatocellular carcinoma
Journal of Vascular and Interventional Radiology. 2018;29(4):S121
Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
Hepatobiliary & Pancreatic Diseases International. 2016;15(2):122-124
Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
Hepatobiliary & Pancreatic Diseases International. 2016;15(2):158-164
Pathological response to pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
HPB. 2016;18:e294-e295
Combination of transarterial chemoembolization and percutaneous local ablation therapy for hepatocellular carcinoma
Hepatology Research. 2010;40(1):105-107
Efficacy and safety of transarterial chemoembolization using drug eluting beads for hepatocellular carcinoma
HPB. 2016;18:e220
Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome
Journal of Vascular and Interventional Radiology. 2016;27(9):1269-1278